MXPA05002701A - Agentes antibacterianos de tetrahidroquinolina triciclicos. - Google Patents

Agentes antibacterianos de tetrahidroquinolina triciclicos.

Info

Publication number
MXPA05002701A
MXPA05002701A MXPA05002701A MXPA05002701A MXPA05002701A MX PA05002701 A MXPA05002701 A MX PA05002701A MX PA05002701 A MXPA05002701 A MX PA05002701A MX PA05002701 A MXPA05002701 A MX PA05002701A MX PA05002701 A MXPA05002701 A MX PA05002701A
Authority
MX
Mexico
Prior art keywords
tetrahydro
oxazino
quinolin
dimethyl
optionally substituted
Prior art date
Application number
MXPA05002701A
Other languages
English (en)
Spanish (es)
Inventor
Peter Laurence Toogood
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of MXPA05002701A publication Critical patent/MXPA05002701A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MXPA05002701A 2002-10-07 2003-10-03 Agentes antibacterianos de tetrahidroquinolina triciclicos. MXPA05002701A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41668502P 2002-10-07 2002-10-07
US42718902P 2002-11-18 2002-11-18
US45762203P 2003-03-26 2003-03-26
PCT/IB2003/004389 WO2004031195A1 (en) 2002-10-07 2003-10-03 Tricyclic tetrahydroquinoline antibacterial agents

Publications (1)

Publication Number Publication Date
MXPA05002701A true MXPA05002701A (es) 2005-08-19

Family

ID=32074379

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05002701A MXPA05002701A (es) 2002-10-07 2003-10-03 Agentes antibacterianos de tetrahidroquinolina triciclicos.

Country Status (16)

Country Link
US (4) US7208490B2 (cg-RX-API-DMAC7.html)
EP (1) EP1551849B1 (cg-RX-API-DMAC7.html)
JP (1) JP4009652B2 (cg-RX-API-DMAC7.html)
AR (1) AR041546A1 (cg-RX-API-DMAC7.html)
AT (1) ATE473985T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003264768A1 (cg-RX-API-DMAC7.html)
BR (1) BR0315139A (cg-RX-API-DMAC7.html)
CA (1) CA2500824C (cg-RX-API-DMAC7.html)
CY (1) CY1110821T1 (cg-RX-API-DMAC7.html)
DE (1) DE60333379D1 (cg-RX-API-DMAC7.html)
DK (1) DK1551849T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA05002701A (cg-RX-API-DMAC7.html)
PT (1) PT1551849E (cg-RX-API-DMAC7.html)
SI (1) SI1551849T1 (cg-RX-API-DMAC7.html)
TW (1) TWI295671B (cg-RX-API-DMAC7.html)
WO (1) WO2004031195A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
CA2606847A1 (en) * 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
RU2010103101A (ru) * 2007-07-02 2011-08-10 Астразенека Аб (Se) Химические соединения
US20110178064A1 (en) 2007-07-16 2011-07-21 Astrazeneca R&D Spiro condensed barbituric acid derivatives for use as antibacterial
TW201020258A (en) * 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
RU2505539C2 (ru) * 2008-12-23 2014-01-27 Эбботт Лэборетриз Антивирусные соединения
NZ705225A (en) 2010-07-16 2016-11-25 Abbvie Bahamas Ltd Process for preparing antiviral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
US8841487B2 (en) 2010-07-16 2014-09-23 Abbvie Inc. Phosphine ligands for catalytic reactions
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
WO2014042647A1 (en) * 2012-09-14 2014-03-20 Levina Elizabeth Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
SG11201609404SA (en) 2014-05-29 2016-12-29 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
US10995097B2 (en) * 2016-03-11 2021-05-04 The Board Of Trustees Of The University Of Illinois Small molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
CN108101860B (zh) * 2018-02-08 2021-11-23 苏州敬业医药化工有限公司 顺式-2,6-二甲基吗啉的制备方法
CN115466212B (zh) * 2022-10-26 2023-09-22 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用
CN118878546B (zh) * 2024-09-30 2025-01-03 苏州大学 一种螺环巴比妥酸衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
CZ20031083A3 (cs) 2000-10-26 2004-03-17 Pfizer Products Inc. 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
WO2004033449A1 (en) 2002-10-10 2004-04-22 Pharmacia & Upjohn Company Llc Antimicrobial 1-aryl dihydropyridone compounds

Also Published As

Publication number Publication date
CY1110821T1 (el) 2015-06-10
PT1551849E (pt) 2010-09-27
ATE473985T1 (de) 2010-07-15
CA2500824C (en) 2011-03-22
JP2006511595A (ja) 2006-04-06
US20110092494A1 (en) 2011-04-21
TWI295671B (en) 2008-04-11
US7605157B2 (en) 2009-10-20
TW200413394A (en) 2004-08-01
BR0315139A (pt) 2005-08-09
WO2004031195A1 (en) 2004-04-15
JP4009652B2 (ja) 2007-11-21
EP1551849B1 (en) 2010-07-14
SI1551849T1 (sl) 2010-11-30
US7208490B2 (en) 2007-04-24
DK1551849T3 (da) 2010-10-25
DE60333379D1 (de) 2010-08-26
US8420646B2 (en) 2013-04-16
US20070161630A1 (en) 2007-07-12
US20100022524A1 (en) 2010-01-28
CA2500824A1 (en) 2004-04-15
US20040162279A1 (en) 2004-08-19
AU2003264768A1 (en) 2004-04-23
AR041546A1 (es) 2005-05-18
EP1551849A1 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
US8420646B2 (en) Tricyclic tetrahydroquinoline antibacterial agents
AU2018244349B2 (en) Compounds that inhibit Mcl-1 protein
EP2595989B1 (en) Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US7863291B2 (en) Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
US9593129B2 (en) Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
US9365588B2 (en) Benzoxazines as modulators of ion channels
US20100099684A1 (en) Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
KR102731924B1 (ko) 파르네소이드 x 수용체 조정제로서의 스피로시클릭 화합물
CN113767092B (zh) 双杂环羰基取代的二氢吡唑类化合物,其制法与医药上的用途
US9096615B2 (en) Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
IE65712B1 (en) Isoxazole-beta-carboline derivatives
CN114478528A (zh) 芳甲酰取代的三环化合物及其制法和用途
TWI838644B (zh) 芳甲醯取代的三環化合物及其製法和用途
ES2347958T3 (es) Agentes antibacterianos de tetrahidroquinolina triciclica.
HK40096984A (en) Aroyl substituted tricyclic compound, preparation method therefor and use thereof
HK40064285A (en) Bisheterocyclic carbonyl substituted dihydropyrazole compound, preparation method therefor and pharmaceutical use thereof
HK1185618B (en) Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
HC Change of company name or juridical status